Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
August 7, 2025	8-K	Report of unscheduled material events or corporate event	0001517022-25-000034.pdf 0001517022-25-000034.rtf 0001517022-25-000034.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 7, 2025	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-25-038600.pdf 0001628280-25-038600.rtf 0001628280-25-038600.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 7, 2025	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-25-175015.pdf 0001193125-25-175015.rtf 0001193125-25-175015.xls View HTML
July 1, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-005201.pdf 0001562180-25-005201.rtf 0001562180-25-005201.xls View HTML
June 30, 2025	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-25-000031.pdf 0001517022-25-000031.rtf View HTML
June 13, 2025	8-K	Report of unscheduled material events or corporate event	0001517022-25-000030.pdf 0001517022-25-000030.rtf 0001517022-25-000030.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004718.pdf 0001562180-25-004718.rtf 0001562180-25-004718.xls View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004717.pdf 0001562180-25-004717.rtf 0001562180-25-004717.xls View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004719.pdf 0001562180-25-004719.rtf 0001562180-25-004719.xls View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004720.pdf 0001562180-25-004720.rtf 0001562180-25-004720.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax